Logo image of CHR-DB-B.CA

CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:CHR-DB-B - CA17040TAE25

100.4 CAD
+0.39 (+0.39%)
Last: 9/24/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, CHR-DB-B scores 4 out of 10 in our fundamental rating. CHR-DB-B was compared to 5 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR-DB-B get a neutral evaluation. Nothing too spectacular is happening here. CHR-DB-B has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CHR-DB-B had positive earnings in the past year.
In the past year CHR-DB-B had a positive cash flow from operations.
In multiple years CHR-DB-B reported negative net income over the last 5 years.
Each year in the past 5 years CHR-DB-B had a positive operating cash flow.
CHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CHR-DB-B has a Return On Assets of -1.91%. This is in the lower half of the industry: CHR-DB-B underperforms 75.00% of its industry peers.
Looking at the Return On Equity, with a value of -4.82%, CHR-DB-B is doing worse than 62.50% of the companies in the same industry.
CHR-DB-B's Return On Invested Capital of 6.54% is amongst the best of the industry. CHR-DB-B outperforms 87.50% of its industry peers.
CHR-DB-B had an Average Return On Invested Capital over the past 3 years of 5.30%. This is in line with the industry average of 3.84%.
The last Return On Invested Capital (6.54%) for CHR-DB-B is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROIC 6.54%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR-DB-B.CA Yearly ROA, ROE, ROICCHR-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

Looking at the Operating Margin, with a value of 6.87%, CHR-DB-B is in line with its industry, outperforming 50.00% of the companies in the same industry.
CHR-DB-B's Operating Margin has declined in the last couple of years.
The Gross Margin of CHR-DB-B (65.48%) is better than 87.50% of its industry peers.
In the last couple of years the Gross Margin of CHR-DB-B has declined.
Industry RankSector Rank
OM 6.87%
PM (TTM) N/A
GM 65.48%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR-DB-B.CA Yearly Profit, Operating, Gross MarginsCHR-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHR-DB-B is destroying value.
Compared to 1 year ago, CHR-DB-B has less shares outstanding
Compared to 5 years ago, CHR-DB-B has more shares outstanding
The debt/assets ratio for CHR-DB-B has been reduced compared to a year ago.
CHR-DB-B.CA Yearly Shares OutstandingCHR-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR-DB-B.CA Yearly Total Debt VS Total AssetsCHR-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.38 indicates that CHR-DB-B is not a great score, but indicates only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.38, CHR-DB-B belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
The Debt to FCF ratio of CHR-DB-B is 7.89, which is on the high side as it means it would take CHR-DB-B, 7.89 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.89, CHR-DB-B belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
CHR-DB-B has a Debt/Equity ratio of 0.54. This is a neutral value indicating CHR-DB-B is somewhat dependend on debt financing.
CHR-DB-B's Debt to Equity ratio of 0.54 is amongst the best of the industry. CHR-DB-B outperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Altman-Z 2.38
ROIC/WACC0.75
WACC8.76%
CHR-DB-B.CA Yearly LT Debt VS Equity VS FCFCHR-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CHR-DB-B has a Current Ratio of 1.14. This is a normal value and indicates that CHR-DB-B is financially healthy and should not expect problems in meeting its short term obligations.
CHR-DB-B's Current ratio of 1.14 is on the low side compared to the rest of the industry. CHR-DB-B is outperformed by 62.50% of its industry peers.
A Quick Ratio of 0.61 indicates that CHR-DB-B may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.61, CHR-DB-B is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.61
CHR-DB-B.CA Yearly Current Assets VS Current LiabilitesCHR-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 78.57% over the past year.
Measured over the past years, CHR-DB-B shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.03% on average per year.
The Revenue for CHR-DB-B has decreased by -13.36% in the past year. This is quite bad
CHR-DB-B shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.56% yearly.
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%

3.2 Future

CHR-DB-B is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.21% yearly.
The Revenue is expected to decrease by -5.14% on average over the next years.
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHR-DB-B.CA Yearly Revenue VS EstimatesCHR-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR-DB-B.CA Yearly EPS VS EstimatesCHR-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 44.62, CHR-DB-B can be considered very expensive at the moment.
62.50% of the companies in the same industry are cheaper than CHR-DB-B, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CHR-DB-B to the average of the S&P500 Index (26.92), we can say CHR-DB-B is valued expensively.
CHR-DB-B is valuated quite expensively with a Price/Forward Earnings ratio of 52.09.
Based on the Price/Forward Earnings ratio, CHR-DB-B is valued a bit more expensive than 62.50% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CHR-DB-B to the average of the S&P500 Index (23.46), we can say CHR-DB-B is valued expensively.
Industry RankSector Rank
PE 44.62
Fwd PE 52.09
CHR-DB-B.CA Price Earnings VS Forward Price EarningsCHR-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR-DB-B is valued a bit more expensive than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CHR-DB-B is valued a bit cheaper than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 52.76
EV/EBITDA 13.62
CHR-DB-B.CA Per share dataCHR-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y12.98%
EPS Next 3Y1.21%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.42%, CHR-DB-B has a reasonable but not impressive dividend return.
CHR-DB-B's Dividend Yield is a higher than the industry average which is at 0.96.
CHR-DB-B's Dividend Yield is slightly below the S&P500 average, which is at 2.00.
Industry RankSector Rank
Dividend Yield 1.42%

5.2 History

The dividend of CHR-DB-B is nicely growing with an annual growth rate of 21.58%!
CHR-DB-B is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CHR-DB-B has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHR-DB-B is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-34.57%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
CHR-DB-B.CA Yearly Income VS Free CF VS DividendCHR-DB-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR-DB-B (9/24/2025, 7:00:00 PM)

100.4

+0.39 (+0.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners3.2%
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap2.57B
Revenue(TTM)1.37B
Net Income(TTM)-25.87M
Analysts78
Price Target133.9 (33.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.42%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-34.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)3.87%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)3.87%
Max EPS beat(4)207.96%
EPS beat(8)5
Avg EPS beat(8)11.1%
EPS beat(12)6
Avg EPS beat(12)4.98%
EPS beat(16)8
Avg EPS beat(16)3.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.13%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-3.95%
Revenue beat(4)0
Avg Revenue beat(4)-6%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-2.48%
Revenue beat(12)5
Avg Revenue beat(12)-1.45%
Revenue beat(16)8
Avg Revenue beat(16)1.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1.03%
EPS NQ rev (3m)-5.64%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.29%
Revenue NQ rev (1m)-0.89%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 44.62
Fwd PE 52.09
P/S 1.88
P/FCF 52.76
P/OCF 30.38
P/B 4.78
P/tB 4.86
EV/EBITDA 13.62
EPS(TTM)2.25
EY2.24%
EPS(NY)1.93
Fwd EY1.92%
FCF(TTM)1.9
FCFY1.9%
OCF(TTM)3.3
OCFY3.29%
SpS53.45
BVpS20.99
TBVpS20.65
PEG (NY)0.81
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROCE 8.82%
ROIC 6.54%
ROICexc 6.9%
ROICexgc 6.96%
OM 6.87%
PM (TTM) N/A
GM 65.48%
FCFM 3.56%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Debt/EBITDA 1.36
Cap/Depr 30.21%
Cap/Sales 2.62%
Interest Coverage 2.06
Cash Conversion 39.75%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.61
Altman-Z 2.38
F-Score5
WACC8.76%
ROIC/WACC0.75
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-53.02%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year86.18%
EBIT Next 3Y12.53%
EBIT Next 5YN/A
FCF growth 1Y-79.47%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-70.44%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR-DB-B.CA FAQ

Can you provide the ChartMill fundamental rating for CHORUS AVIATION INC?

ChartMill assigns a fundamental rating of 4 / 10 to CHR-DB-B.CA.


What is the valuation status of CHORUS AVIATION INC (CHR-DB-B.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to CHORUS AVIATION INC (CHR-DB-B.CA). This can be considered as Overvalued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR-DB-B.CA) has a profitability rating of 4 / 10.


Can you provide the financial health for CHR-DB-B stock?

The financial health rating of CHORUS AVIATION INC (CHR-DB-B.CA) is 5 / 10.


Can you provide the expected EPS growth for CHR-DB-B stock?

The Earnings per Share (EPS) of CHORUS AVIATION INC (CHR-DB-B.CA) is expected to grow by 55.31% in the next year.